# EchoGuide by ASE vs CardioGenetics

The clearest difference is price: EchoGuide by ASE at Free against CardioGenetics's $2.99. EchoGuide by ASE also leads on update cadence (monthly vs every 5 months) and ratings volume (41 vs 4). CardioGenetics's advantage is review sentiment (100% vs 75%) and rating (5.0 vs 4.7). On ads, in-app purchases and device support there is nothing between them.

EchoGuide by ASE is free to download; CardioGenetics costs $2.99 up front. Neither carries in-app purchases, so what you see is what you pay.

CardioGenetics holds the better App Store score, 5.0 against 4.7. That said, the two scores are not equally well evidenced: EchoGuide by ASE has 41 ratings behind it against 4, so its average is the more settled of the two. Written reviews point the same way: 75% of EchoGuide by ASE's written reviews are positive against 100% of CardioGenetics's.

EchoGuide by ASE ships an update monthly, CardioGenetics every 5 months. The most recent releases landed on October 14, 2026 and September 23, 2026 respectively.

## The numbers

| Metric | EchoGuide by ASE | CardioGenetics |
| --- | --- | --- |
| Price | **Free** | $2.99 |
| Rating | [4.7 (41 ratings)](https://appshunter.io/ios/app/echoguide-by-ase/id1582601048/reviews) | **[5.0 (4 ratings)](https://appshunter.io/ios/app/cardiogenetics/id6760680270/reviews)** |
| Number of ratings | **41** | 4 |
| Positive reviews | 75.0% of reviews | **100.0% of reviews** |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | **Monthly** | Every 5 months |
| Monetization | **Free** | Paid |
| Size | 96 MB | 6 MB |
| Requires iOS | **14.2** | 17.0 |
| Devices | **iPhone, iPad, iPod** | iPhone, iPad |
| Age rating | 12+ | 4+ |
| Developer | [American Society of Echocardiography](https://appshunter.io/developer/421031128) | [MARK EMILE PEPIN](https://appshunter.io/developer/1885696464) |

## What reviewers say

### EchoGuide by ASE

[App page](https://appshunter.io/ios/app/echoguide-by-ase/id1582601048)

This medical app offers over 50 calculators, algorithms, and charts based on key guidelines for cardiac care professionals. It allows users to favorite interactive tools for quick access to a wide range of echocardiography measurements and assessments.

**Highlights:** Over 50 calculators, algorithms, and charts, Based on ASE guidelines, Favorite interactive tools, Cardiac care reference, Echocardiography measurements

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### CardioGenetics

[App page](https://appshunter.io/ios/app/cardiogenetics/id6760680270)

This medical app provides healthcare professionals with validated calculators, diagnostic frameworks, and a clinical trial finder for inherited cardiomyopathies. It offers evidence-based risk stratification aligned with current guidelines, supporting clinical decision-making at the bedside and in conference.

**Highlights:** Validated risk calculators, Diagnostic frameworks, Clinical trial finder, Guideline-linked evidence, Gene-specific risk assessment, ASCVD risk calculation

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is EchoGuide by ASE free?

EchoGuide by ASE is free to download, with no in-app purchases.

### Is CardioGenetics free?

CardioGenetics costs $2.99, with no in-app purchases.

### Which has better reviews, EchoGuide by ASE or CardioGenetics?

CardioGenetics is rated higher. EchoGuide by ASE averages 4.7 out of 5 from 41 ratings, while CardioGenetics averages 5.0 from 4 ratings.

### Do EchoGuide by ASE or CardioGenetics have ads?

Neither EchoGuide by ASE nor CardioGenetics shows ads.

### Which is updated more often, EchoGuide by ASE or CardioGenetics?

EchoGuide by ASE ships an update monthly, and CardioGenetics every 5 months. Most recently, EchoGuide by ASE was updated on October 14, 2026 and CardioGenetics on September 23, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*